HK1214597A1 - 苯甲酰基 -吡咯烷- -羰基 -吡咯烷- -甲腈衍生物 - Google Patents
苯甲酰基 -吡咯烷- -羰基 -吡咯烷- -甲腈衍生物Info
- Publication number
- HK1214597A1 HK1214597A1 HK16102568.0A HK16102568A HK1214597A1 HK 1214597 A1 HK1214597 A1 HK 1214597A1 HK 16102568 A HK16102568 A HK 16102568A HK 1214597 A1 HK1214597 A1 HK 1214597A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrrolidine
- benzoyl
- carbonyl
- carbonitrile derivatives
- carbonitrile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382446.8A EP2730571A1 (en) | 2012-11-12 | 2012-11-12 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
PCT/EP2013/073460 WO2014072498A1 (en) | 2012-11-12 | 2013-11-11 | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1214597A1 true HK1214597A1 (zh) | 2016-07-29 |
Family
ID=47278735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16102568.0A HK1214597A1 (zh) | 2012-11-12 | 2016-03-07 | 苯甲酰基 -吡咯烷- -羰基 -吡咯烷- -甲腈衍生物 |
Country Status (25)
Country | Link |
---|---|
US (2) | US10125097B2 (zh) |
EP (2) | EP2730571A1 (zh) |
JP (1) | JP6203278B2 (zh) |
KR (1) | KR102151290B1 (zh) |
CN (1) | CN104903314B (zh) |
AU (1) | AU2013343430B2 (zh) |
BR (1) | BR112015010377A8 (zh) |
CA (1) | CA2890042C (zh) |
CY (1) | CY1118818T1 (zh) |
DK (1) | DK2917209T3 (zh) |
EA (1) | EA028422B1 (zh) |
ES (1) | ES2621672T3 (zh) |
HK (1) | HK1214597A1 (zh) |
HR (1) | HRP20170485T1 (zh) |
HU (1) | HUE032472T2 (zh) |
LT (1) | LT2917209T (zh) |
ME (1) | ME02706B (zh) |
MX (1) | MX367488B (zh) |
NZ (1) | NZ709096A (zh) |
PL (1) | PL2917209T3 (zh) |
PT (1) | PT2917209T (zh) |
RS (1) | RS55865B1 (zh) |
SI (1) | SI2917209T1 (zh) |
WO (1) | WO2014072498A1 (zh) |
ZA (1) | ZA201504269B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2730571A1 (en) | 2012-11-12 | 2014-05-14 | Universitat De Barcelona | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
EP3031458A1 (en) * | 2014-12-09 | 2016-06-15 | Iproteos S.L. | Use of 1-[(2-phenylcycloprop-1-yl)carbonyl]-2-[(1,3-thiazolidin-3-yl)carbonyl]perhydroindole in the treatment of schizophrenia-associated cognitive deficits |
AU2018386298B2 (en) | 2017-12-15 | 2023-09-07 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
EP3898654A4 (en) | 2018-12-21 | 2022-10-26 | Praxis Biotech LLC | FIBROBLAST ACTIVATION PROTEIN INHIBITORS |
JP2023533932A (ja) | 2020-07-07 | 2023-08-07 | アクレ セラピューティクス ソシエダッド リミターダ | 1-[1-(4-ベンジルオキシ-3,5-ジフルオロ-ベンゾイル)-4-フルオロ-ピロリジン-2-カルボニル]-ピロリジン-2-カルボニトリル |
CN117062824A (zh) * | 2020-12-28 | 2023-11-14 | 砂拉越生物多元化中心 | 治疗神经退行性疾病的化合物及其分离方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0536163A1 (en) * | 1990-06-04 | 1993-04-14 | Pfizer Inc. | Aromatic pyrrolidine and thiazolidine amides |
US6159938A (en) | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
HUT76640A (en) * | 1995-08-17 | 1997-10-28 | Chinoin Gyogyszer Es Vegyeszet | Compounds of pharmaceutical activity cyclic amide derivatives, pharmaceutical compositions containing them, process for producing them and their use |
DE19603510A1 (de) | 1996-02-01 | 1997-08-07 | Knoell Hans Forschung Ev | Die Verwendung von Terrecyclolsäure A und Terrecyclolsäure A-Derivate als neue Inhibitoren der humanen Prolyl-Oligopeptidase |
JP4068452B2 (ja) * | 2000-07-19 | 2008-03-26 | エフ.ホフマン−ラ ロシュ アーゲー | エンドセリン変換酵素阻害剤としてのピロリジン誘導体 |
FI20011466A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö |
FI20030014A0 (fi) | 2003-01-03 | 2003-01-03 | Orion Corp | Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä |
FI20031018A0 (fi) | 2003-07-04 | 2003-07-04 | Orion Corp | Parannus aivovammasta toipumiseen |
WO2005027934A1 (ja) | 2003-09-24 | 2005-03-31 | Nippon Kayaku Kabushiki Kaisha | プロリルオリゴペプチダーゼ阻害剤 |
US7667044B2 (en) | 2003-11-03 | 2010-02-23 | Probiodrug Ag | Compounds for the treatment of neurological disorders |
EP1760076A1 (en) * | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitors |
ES2302473B1 (es) | 2006-12-22 | 2009-06-12 | Universidad De Barcelona | Agente terapeutico para el tratamiento del desorden afectivo bipolar en mamiferos. |
EP2389176A4 (en) * | 2009-01-23 | 2012-08-01 | Univ Sydney | NEW THERAPY FOR METABOLIC DISEASE |
EP2730571A1 (en) | 2012-11-12 | 2014-05-14 | Universitat De Barcelona | 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives |
-
2012
- 2012-11-12 EP EP12382446.8A patent/EP2730571A1/en not_active Withdrawn
-
2013
- 2013-11-11 CA CA2890042A patent/CA2890042C/en active Active
- 2013-11-11 NZ NZ709096A patent/NZ709096A/en unknown
- 2013-11-11 JP JP2015541169A patent/JP6203278B2/ja active Active
- 2013-11-11 SI SI201330601A patent/SI2917209T1/sl unknown
- 2013-11-11 EA EA201590942A patent/EA028422B1/ru not_active IP Right Cessation
- 2013-11-11 ES ES13794837.8T patent/ES2621672T3/es active Active
- 2013-11-11 DK DK13794837.8T patent/DK2917209T3/en active
- 2013-11-11 AU AU2013343430A patent/AU2013343430B2/en active Active
- 2013-11-11 PL PL13794837T patent/PL2917209T3/pl unknown
- 2013-11-11 HU HUE13794837A patent/HUE032472T2/en unknown
- 2013-11-11 PT PT137948378T patent/PT2917209T/pt unknown
- 2013-11-11 WO PCT/EP2013/073460 patent/WO2014072498A1/en active Application Filing
- 2013-11-11 MX MX2015005931A patent/MX367488B/es active IP Right Grant
- 2013-11-11 US US14/436,715 patent/US10125097B2/en active Active
- 2013-11-11 LT LTEP13794837.8T patent/LT2917209T/lt unknown
- 2013-11-11 CN CN201380059126.XA patent/CN104903314B/zh active Active
- 2013-11-11 KR KR1020157015736A patent/KR102151290B1/ko active IP Right Grant
- 2013-11-11 RS RS20170362A patent/RS55865B1/sr unknown
- 2013-11-11 BR BR112015010377A patent/BR112015010377A8/pt not_active Application Discontinuation
- 2013-11-11 ME MEP-2017-76A patent/ME02706B/me unknown
- 2013-11-11 EP EP13794837.8A patent/EP2917209B1/en active Active
-
2015
- 2015-06-12 ZA ZA2015/04269A patent/ZA201504269B/en unknown
-
2016
- 2016-03-07 HK HK16102568.0A patent/HK1214597A1/zh unknown
-
2017
- 2017-03-22 HR HRP20170485TT patent/HRP20170485T1/hr unknown
- 2017-04-06 CY CY20171100410T patent/CY1118818T1/el unknown
-
2018
- 2018-09-26 US US16/142,907 patent/US10611727B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209747A1 (zh) | 環烷基羰基 脯氨酸衍生物 | |
ZA201407632B (en) | Triazolone compounds as mpges-1 inhibitors | |
HK1214597A1 (zh) | 苯甲酰基 -吡咯烷- -羰基 -吡咯烷- -甲腈衍生物 | |
EP2884977A4 (en) | N-ALKYLATED INDAZOLE AND INDOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF | |
HK1207854A1 (zh) | 作為因子 抑制劑用於治療血栓栓塞疾病的取代的吡咯烷 | |
HK1216147A1 (zh) | 取代的苯甲酰基 -氟- -亞氨基- -甲基- -二氫嘧啶- -酮衍生物 | |
HK1202543A1 (zh) | 氮雜環化合物 | |
CO6801714A2 (es) | 1-(heterociclico carbonil)-pirrolidinas 2-sustituidas | |
HK1202860A1 (zh) | 新的 -取代的吲唑衍生物 | |
GB2511705B (en) | Torsion clamp | |
HK1213253A1 (zh) | 新型吡唑衍生物 | |
GB201508634D0 (en) | Single side screen clamping | |
ZA201407177B (en) | Fused azole derivative | |
EP2849916A4 (en) | WELD VOLTAGE COMPENSATION SYSTEM | |
PL2733085T3 (pl) | Rama do palet | |
AU346536S (en) | Jaw plate clamping bar | |
HK1221954A1 (zh) | β- -吡喃葡糖基 -吲哚化合物 | |
EP2934144A4 (en) | INDAZOL COMPOUNDS AS AN ALDOSTERONE SYNTHESIS HEMMER | |
AU5027P (en) | Cha Cha Cordyline australis | |
GB201202400D0 (en) | Nitrogen-containing heterocyclic compounds | |
GB201219296D0 (en) | Pyrazole derivatives | |
TWM433161U (en) | Cup-placing rack | |
AU343635S (en) | Off-set pivot clamp |